Revvity Inc
24/7 Wall St. View
RVTY at a Glance
- 24/7 target
- $168.08
- Street target
- $132.87
NYSE: RVTY
About Revvity
Revvity Inc, formerly known as PerkinElmer, is a global provider of health sciences solutions, technologies, and services. With a focus on Life Sciences and Diagnostics, the company offers a wide range of products including instruments, reagents, software, and services for genetic disorder detection and infectious disease testing. Its innovative technologies support genomic workflows in oncology, immunodiagnostics, and drug discovery. Serving a diverse clientele, from pharmaceutical companies to academic institutions, Revvity is a key player in advancing healthcare research and diagnostics. Founded in 1937, it is headquartered in Waltham, Massachusetts.
Frequently Asked Questions
What does Revvity do?
Revvity Inc, formerly known as PerkinElmer, is a global provider of health sciences solutions, technologies, and services.
What is the RVTY stock price target?
24/7 Wall St.'s 12-month price target for RVTY is $168.08, rated Buy. The Wall Street consensus target is $132.87. RVTY price prediction →